enCore Energy Corp. Logo

enCore Energy Corp.

American uranium producer using ISR technology to fuel the U.S. nuclear energy sector.

EU | US

Overview

Corporate Details

ISIN(s):
CA29259W7008 (+1 more)
LEI:
Country:
United States of America
Address:
101 N. SHORELINE BLVD, SUITE 450, 78401 CORPUS CHRISTI
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

enCore Energy Corp. is an American uranium production company focused on providing fuel for the U.S. nuclear energy sector. The company specializes in and solely utilizes In-Situ Recovery (ISR), a proven, lower-cost, and environmentally friendly uranium extraction technology. enCore is a key domestic supplier, distinguished by operating multiple Central Processing Plants, including its Rosita and Alta Mesa facilities in South Texas, which commenced production in 2023 and 2024. The company maintains a robust growth pipeline with advanced-stage development projects, including the Dewey Burdock project in South Dakota and the Gas Hills project in Wyoming, to support the long-term demand for clean nuclear energy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all enCore Energy Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for enCore Energy Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for enCore Energy Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America MBRX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Moolec Science SA Logo
Uses Molecular Farming to grow animal proteins in plants for food, feed, and supplement industries.
United States of America MLEC
MoonLake Immunotherapeutics Logo
Developing Nanobody therapies for inflammatory and immunologic diseases like psoriatic arthritis.
United States of America MLTX
Mural Oncology plc Logo
Developing cytokine-based immunotherapies for difficult-to-treat cancers and solid tumors.
United States of America MURA
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
Ireland MURA
N2OFF, Inc. Logo
Sustainable agri-tech for food preservation, emissions reduction, and renewable energy.
United States of America NITO
NANO MRNA Co.,Ltd. Logo
Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.
Japan 4571

Talk to a Data Expert

Have a question? We'll get back to you promptly.